about
Phosphodiesterase type 5 inhibitors and kidney disease.Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging drugs for chronic kidney disease.
@ast
Emerging drugs for chronic kidney disease.
@en
Emerging drugs for chronic kidney disease.
@nl
type
label
Emerging drugs for chronic kidney disease.
@ast
Emerging drugs for chronic kidney disease.
@en
Emerging drugs for chronic kidney disease.
@nl
prefLabel
Emerging drugs for chronic kidney disease.
@ast
Emerging drugs for chronic kidney disease.
@en
Emerging drugs for chronic kidney disease.
@nl
P2093
P2860
P1476
Emerging drugs for chronic kidney disease.
@en
P2093
Giuseppe Cianciolo
Maria Laura Angelini
Mario Iorio
Olga Baraldi
Sergio Stefoni
P2860
P304
P356
10.1517/14728214.2014.900044
P407
P577
2014-05-16T00:00:00Z